These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12219268)

  • 1. [Oral antibiotics with antiinflammatory/ immunomodulatory effects in the treatment of various dermatoses].
    Brinkmeier T; Frosch PJ
    Hautarzt; 2002 Jul; 53(7):456-65. PubMed ID: 12219268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulation in autoimmune diseases.
    Gergely P; Láng I; Gonzalez-Cabello R; Fehér J
    Tokai J Exp Clin Med; 1986; 11 Suppl():207-13. PubMed ID: 3452243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory activity of tetracyclines.
    Webster G; Del Rosso JQ
    Dermatol Clin; 2007 Apr; 25(2):133-5, v. PubMed ID: 17430750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid].
    Worret WI; Fluhr JW
    J Dtsch Dermatol Ges; 2006 Apr; 4(4):293-300. PubMed ID: 16638058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of C3d and C4d immunohistochemistry on formalin-fixed tissue as a diagnostic adjunct in the assessment of inflammatory skin disease.
    Magro CM; Dyrsen ME
    J Am Acad Dermatol; 2008 Nov; 59(5):822-33. PubMed ID: 19119098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of corticoid-antibiotic combinations in local treatments. Critical study].
    Revuz J; Duterque M; Escande JP
    Ann Dermatol Venereol; 1983; 110(12):1007-10. PubMed ID: 6364924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implications of aging skin: cutaneous disorders in the elderly.
    Farage MA; Miller KW; Berardesca E; Maibach HI
    Am J Clin Dermatol; 2009; 10(2):73-86. PubMed ID: 19222248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrolides in chronic inflammatory skin disorders.
    Alzolibani AA; Zedan K
    Mediators Inflamm; 2012; 2012():159354. PubMed ID: 22685371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune bullous dermatoses: a review.
    Patrício P; Ferreira C; Gomes MM; Filipe P
    Ann N Y Acad Sci; 2009 Sep; 1173():203-10. PubMed ID: 19758152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-based treatment options for the management of skin toxicities associated with epidermal growth factor receptor inhibitors.
    Tan EH; Chan A
    Ann Pharmacother; 2009 Oct; 43(10):1658-66. PubMed ID: 19755624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined activation of innate and T cell immunity for recognizing immunomodulatory properties of therapeutic agents.
    Rose B; Herder C; Löffler H; Kolb H; Martin S
    J Leukoc Biol; 2004 Apr; 75(4):624-30. PubMed ID: 14704370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common and alternate oral antibiotic therapies for acne vulgaris: a review.
    Amin K; Riddle CC; Aires DJ; Schweiger ES
    J Drugs Dermatol; 2007 Sep; 6(9):873-80. PubMed ID: 17941358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab in refractory autoimmune bullous diseases.
    Schmidt E; Hunzelmann N; Zillikens D; Bröcker EB; Goebeler M
    Clin Exp Dermatol; 2006 Jul; 31(4):503-8. PubMed ID: 16716150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infections and autoimmune diseases.
    Bach JF
    J Autoimmun; 2005; 25 Suppl():74-80. PubMed ID: 16278064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of dapsone in the treatment of pemphigus and pemphigoid: analysis of current data.
    Gürcan HM; Ahmed AR
    Am J Clin Dermatol; 2009; 10(6):383-96. PubMed ID: 19824739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for anti-inflammatory activities of oral synthetic retinoids: experimental findings and clinical experience.
    Orfanos CE; Bauer R
    Br J Dermatol; 1983 Jul; 109 Suppl 25():55-60. PubMed ID: 6222758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose intravenous immunoglobulins: an option in the treatment of systemic lupus erythematosus.
    Toubi E; Kessel A; Shoenfeld Y
    Hum Immunol; 2005 Apr; 66(4):395-402. PubMed ID: 15866703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Practical management of the most common autoimmune bullous diseases].
    Suárez-Fernández R; España-Alonso A; Herrero-González JE; Mascaró-Galy JM
    Actas Dermosifiliogr; 2008; 99(6):441-55. PubMed ID: 18558052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic vasculitis: still a challenging disease.
    Buhaescu I; Covic A; Levy J
    Am J Kidney Dis; 2005 Aug; 46(2):173-85. PubMed ID: 16112036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.